Cargando…
Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT
Gastric cancer is one of the most common malignancies worldwide and vasculogenic mimicry (VM) is considered to be the leading cause for the failure of anti-angiogenesis therapy in advanced gastric cancer patients. In the present study, we investigate the role of tenascin-c (TNC) in the formation of...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481562/ https://www.ncbi.nlm.nih.gov/pubmed/34588421 http://dx.doi.org/10.1038/s41419-021-04153-1 |
_version_ | 1784576700204449792 |
---|---|
author | Kang, Xing Xu, En Wang, Xingzhou Qian, Lulu Yang, Zhi Yu, Heng Wang, Chao Ren, Chuanfu Wang, Yizhou Lu, Xiaofeng Xia, Xuefeng Guan, Wenxian Qiao, Tong |
author_facet | Kang, Xing Xu, En Wang, Xingzhou Qian, Lulu Yang, Zhi Yu, Heng Wang, Chao Ren, Chuanfu Wang, Yizhou Lu, Xiaofeng Xia, Xuefeng Guan, Wenxian Qiao, Tong |
author_sort | Kang, Xing |
collection | PubMed |
description | Gastric cancer is one of the most common malignancies worldwide and vasculogenic mimicry (VM) is considered to be the leading cause for the failure of anti-angiogenesis therapy in advanced gastric cancer patients. In the present study, we investigate the role of tenascin-c (TNC) in the formation of VM in gastric cancer and found that TNC was upregulated in gastric cancer tissue than in the corresponding adjacent tissues and correlated with VM and poor prognosis of gastric cancer. Furthermore, knockdown of TNC significantly inhibited VM formation and proliferation of gastric cancer cells in vitro and in vivo, with a reduction in cell migration and invasion. Mechanistically, TNC knockdown suppressed the phosphorylation of ERK and subsequently inhibited the process of EMT, both of which play an important role in VM formation. Our results indicated that TNC plays an important role in VM formation in gastric cancer. Combining inhibition of TNC and ERK may be a potential therapeutic approach to inhibit gastric cancer growth and metastasis and decrease antiangiogenic therapeutic resistance. |
format | Online Article Text |
id | pubmed-8481562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84815622021-10-08 Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT Kang, Xing Xu, En Wang, Xingzhou Qian, Lulu Yang, Zhi Yu, Heng Wang, Chao Ren, Chuanfu Wang, Yizhou Lu, Xiaofeng Xia, Xuefeng Guan, Wenxian Qiao, Tong Cell Death Dis Article Gastric cancer is one of the most common malignancies worldwide and vasculogenic mimicry (VM) is considered to be the leading cause for the failure of anti-angiogenesis therapy in advanced gastric cancer patients. In the present study, we investigate the role of tenascin-c (TNC) in the formation of VM in gastric cancer and found that TNC was upregulated in gastric cancer tissue than in the corresponding adjacent tissues and correlated with VM and poor prognosis of gastric cancer. Furthermore, knockdown of TNC significantly inhibited VM formation and proliferation of gastric cancer cells in vitro and in vivo, with a reduction in cell migration and invasion. Mechanistically, TNC knockdown suppressed the phosphorylation of ERK and subsequently inhibited the process of EMT, both of which play an important role in VM formation. Our results indicated that TNC plays an important role in VM formation in gastric cancer. Combining inhibition of TNC and ERK may be a potential therapeutic approach to inhibit gastric cancer growth and metastasis and decrease antiangiogenic therapeutic resistance. Nature Publishing Group UK 2021-09-29 /pmc/articles/PMC8481562/ /pubmed/34588421 http://dx.doi.org/10.1038/s41419-021-04153-1 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Kang, Xing Xu, En Wang, Xingzhou Qian, Lulu Yang, Zhi Yu, Heng Wang, Chao Ren, Chuanfu Wang, Yizhou Lu, Xiaofeng Xia, Xuefeng Guan, Wenxian Qiao, Tong Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT |
title | Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT |
title_full | Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT |
title_fullStr | Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT |
title_full_unstemmed | Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT |
title_short | Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT |
title_sort | tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting erk- triggered emt |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481562/ https://www.ncbi.nlm.nih.gov/pubmed/34588421 http://dx.doi.org/10.1038/s41419-021-04153-1 |
work_keys_str_mv | AT kangxing tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT xuen tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT wangxingzhou tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT qianlulu tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT yangzhi tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT yuheng tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT wangchao tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT renchuanfu tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT wangyizhou tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT luxiaofeng tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT xiaxuefeng tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT guanwenxian tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt AT qiaotong tenascincknockdownsuppressesvasculogenicmimicryofgastriccancerbyinhibitingerktriggeredemt |